Page 61 - 南京医科大学学报自然科学版
P. 61

第41卷第2期               何梦钰,丁怡睿,金琳羚,等. 肺高压伴发室上性心律失常危险因素分析[J].
                  2021年2月                     南京医科大学学报(自然科学版),2021,41(02):207-211                       ·211 ·


                    ic thromboembolic pulmonary hypertension[J]. Pulm  ing,2019,35(9):1637-1649
                    Circ,2019,9(1):2045894019834890              [10] 袁小涵,徐      怡,祝因苏,等. 7.0T心脏MR成像在肺动
               [4] TONGERS J,SCHWERDTFEGER B,KLEIN G,et al. In⁃        脉高压大鼠模型右心功能评估中的作用[J]. 南京医科
                    cidence and clinical relevance of supraventricular  大学学报(自然科学版),2019,39(1):131-135
                    tachyarrhythmias in pulmonary hypertension[J]. Am  [11] CHEN S A,TAI C T,YU W C,et al. Right atrial focal atri⁃
                    Heart J,2007,153(1):127-132                        al fibrillation:electrophysiologic characteristics and radio⁃
               [5] MESQUITA J,FERREIRA A M,CAVACO D,et al. Im⁃         frequency catheter ablation[J]. J Cardiovasc Electro⁃
                    pact of prophylactic cavotricuspid isthmus ablation in atri⁃  physiol,1999,10(3):328-335
                    al fibrillation recurrence after a first pulmonary vein isola⁃  [12] ROH S Y,CHOI J I,LEE J Y,et al. Catheter ablation of
                    tion procedure[J]. Int J Cardiol,2018,259:82-87    atrial fibrillation in patients with chronic lung disease[J].
               [6] WALIGORA M,TYRKA A,MISZALSKI⁃JAMKA T,et al.         Circ Arrhythm Electrophysiol,2011,4(6):815-822
                    Right atrium enlargement predicts clinically significant  [13] SMITH B,GENUARDI M V,KOCZO A,et al. Atrial ar⁃
                    supraventricular arrhythmia in patients with pulmonary ar⁃  rhythmias are associated with increased mortality in pul⁃
                    terial hypertension[J]. Heart Lung,2018,47(3):237-242  monary arterial hypertension[J]. Pulm Circ,2018,8(3):
               [7] GUCUK IPEK E,MARINE J,YANG E,et al. Predictors      2045894018790316
                    and incidence of atrial flutter after catheter ablation of  [14] MIDDLETON J T,MAULIK A,LEWIS R,et al. Arrhyth⁃
                    atrial fibrillation[J]. Am J Cardiol,2019,124(11):1690-  mic burden and outcomes in pulmonary arterial hyperten⁃
                    1696                                               sion[J]. Front Med(Lausanne),2019,6:169
               [8] WU L,GUO J,ZHENG L,et al. Atrial remodeling and  [15] CANNILLO M,GROSSO M W,GILI S,et al. Supraven⁃
                    atrial tachyarrhythmias in arrhythmogenic right ventricu⁃  tricular arrhythmias in patients with pulmonary arterial
                    lar cardiomyopathy[J]. Am J Cardiol,2016,118(5):   hypertension[J]. Am J Cardiol,2015,116(12):1883-
                    750-753                                            1889
               [9] BAI Y,YANG J,LIU J,et al. Right atrial function for the  [16] OLSSON K M,NICKEL N P,TONGERS J,et al. Atrial
                    prediction of prognosis in connective tissue disease⁃asso⁃  flutter and fibrillation in patients with pulmonary hyper⁃
                    ciated pulmonary arterial hypertension:a study with two⁃  tension[J]. Int J Cardiol,2013,167(5):2300-2305
                    dimensional speckle tracking[J]. Int J Cardiovasc Imag⁃                 [收稿日期] 2020-04-30



                



               (上接第206页)                                         [17] LEIGH R,MOSTAFA M M,KING E M,et al. An inhaled
                    (2):320-328                                        dose of budesonide induces genes involved in transcrip⁃
               [12] 段榆琳,王宋平. 探讨 AECOPD 患者血清 ACE2 和 NLR                 tion and signaling in the human airways:enhancement of
                    水平与 CAT 评分的相关性[J]. 南京医科大学学报(自                      anti ⁃ and proinflammatory effector genes[J]. Pharmacol
                    然科学版),2019,39(7):997-999                           Res Perspect,2016,4(4):e00243
               [13] KIM V L,COOMBS N A,STAPLES K J,et al. Impact and  [18] 薛  瑾,崔亚楠,陈  平,等. 血嗜酸粒细胞对慢性阻塞
                    associations of eosinophilic inflammation in COPD:analy⁃  性肺疾病急性加重期激素治疗反应性和再入院的预测
                    sis of the AERIS cohort[J]. Eur Respir J,2017,50(4)  价值[J]. 中华结核和呼吸杂志,2019,42(6):426-431

               [14] SALTURK C,KARAKURT Z,ADIGUZEL N,et al. Does  [19] KANG H S,RHEE C K,KIM S K,et al. Comparison of
                    eosinophilic COPD exacerbation have a better patient out⁃  the clinical characteristics and treatment outcomes of pa⁃
                    come than non⁃eosinophilic in the intensive care unit?[J].  tients requiring hospital admission to treat eosinophilic
                    Int J Chron Obstruct Pulmon Dis,2015,10:1837-1846  and neutrophilic exacerbations of COPD[J]. Int J Chron
               [15] DUMAN D,AKSOY E,AGCA M C,et al. The utility of in⁃  Obstruct Pulmon Dis,2016,11:2467-2473
                    flammatory markers to predict readmissions and mortality  [20] MEMON M A,FARYAL S,BROHI N,et al. Role of the
                    in COPD cases with or without eosinophilia[J]. Int J  DECAF score in predicting in⁃hospital mortality in acute
                    Chron Obstruct Pulmon Dis,2015,10:2469-2478        exacerbation of chronic obstructive pulmonary disease
               [16] BARNES P J. Glucocorticosteroids[J]. Handb Exp Phar⁃  [J]. Cureus,2019,11(6):e4826
                    macol,2017,237:93-115                                                   [收稿日期] 2020-06-27
   56   57   58   59   60   61   62   63   64   65   66